Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.

UAE honours Professor Majed Chergui with 'Great Arab Minds' award
UAE announces new cut-off age for KG, Grade 1 school admissions
UAE issues yellow alert as dusty conditions reduce visibility
Traffic diversions in Ras Al Khor for Dubai Metro Blue Line works
UAE set for second phase of single-use plastic ban
Minor earthquake recorded east of Saudi Arabia
World’s Coolest Winter campaign spotlights UAE entrepreneurs
H.H. Sheikh Hamdan highlights social cohesion in 'Dubai Lunch' initiative
Dubai tests drones to clean traffic signals
UAE leaders hail 'enduring bonds of friendship' on Bahrain's National Day
UAE locally produces 3 oncology medicines to strengthen fight against cancer
UAE stands in solidarity with Morocco over deadly flash floods
Dubai mandates front number plates for delivery bikes
UAE condemns drone attack on peacekeeping base in Sudan
UAE condemns Israel’s approval to establish 19 settlements in West Bank
UAE, European Commission Presidents explore closer ties
H.H. Sheikh Hamdan reviews Dubai Customs' innovative progress
UAE, Cyprus Presidents discuss enhancing strategic partnership
Emirates, Dubai Humanitarian launch airbridge for Sri Lanka cyclone victims
